The Artificial Intelligence / Human Intelligence & Immunoinformatics Workshop will take place on June 13 and 14th at the South Street Landing Conference Center in Providence, Rhode Island.
Purpose: This event aims to facilitate discussions and knowledge sharing among users of bioinformatics and immunoinformatics tools. Speakers will describe tools used for the exploration of immune responses and provide case studies featuring applications to biologic drugs and vaccines, and assessment of (biologic and peptide) drug safety and immunogenicity.
Who should attend: The event is tailored for professionals and researchers utilizing bioinformatics and immunoinformatics tools, particularly those involved in studying infectious diseases, immune responses, vaccine development, and drug safety. Participants will have the opportunity to delve into emerging trends and foster collaborations in the rapidly evolving fields of immunoinformatics, computational vaccinology and biologics immuno-engineering. Poster sessions: Please submit a 300-word, one page abstract here.
👉Click here to register.
Organizers:
Annie De Groot, Co-Founder & CSO, EpiVax, Inc.
Rich-Henry Schabowsky, CEO, EpiVax, Inc.
Joan Peckham, Professor Emeritus, Department of Computer Science and Statistics, University of Rhode Island
Tom Sgouros, Research Associate, Computer Science Department, Brown University
Jason Machan, Director, Biostatistics Core, Lifespan
Speakers will include:
Annie De Groot MD, Co-founder & CSO, EpiVax Inc.
Kimberly VanderWaal, PhD, Associate Professor, College of Veterinary Medicine, University of Minnesota
Justin Bahl, PhD, Professor, College of Public Health, University of Georgia
Tom Sgouros, Research Associate, Computer Science Department, Brown University
Joana Fueyo, PhD, Research Affiliate, Machine Learning/AI Research Team, Boston University
Joan Peckham, PhD, Professor Emeritus, Department of Computer Science and Statistics, University of Rhode Island
Mark Kon, PhD, Professor, Mathematics and Statistics, Boston University
Guilhem Richard, PhD, CSO & CTO, EpiVax Therapeutics
Julian Chandler, Associate Director of Discovery Research, Alexion Pharmaceuticals
Brian Roberts, PhD, Director of Preclinical Immunology, EpiVax Inc.
Amy Rosenberg, MD, Sr. Director of Immunology & Protein Therapeutics, EpiVax (Formerly FDA)
Brandon DeKosky, PhD, Professor, Chemical Engineering, MIT
Christopher Langmead, PhD, Executive Director, Amgen
Jeonghoon Sun, PhD, Founder / CEO, Multiverse Pharma
Aimee Mattei, MS, Director of Immunoinformatics, EpiVax Inc.